Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
46
Total 13F shares, excl. options
18.7M
Shares change
-1.98M
Total reported value, excl. options
$55.9M
Value change
-$6.38M
Put/Call ratio
0.95
Number of buys
16
Number of sells
-25
Price
$2.99

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2023

57 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q2 2023.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18.7M shares of 264M outstanding shares and own 7.07% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (6.91M shares), VANGUARD GROUP INC (2.12M shares), BlackRock Inc. (2.06M shares), Artal Group S.A. (850K shares), BANK OF AMERICA CORP /DE/ (678K shares), JPMORGAN CHASE & CO (597K shares), Temasek Holdings (Private) Ltd (567K shares), UBS Group AG (538K shares), STATE STREET CORP (507K shares), and MORGAN STANLEY (444K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.